Bordetella pertussis Filamentous Hemagglutinin (FHA)
Selected Variant
OONB00067-200UG
Size: 200 µg
Purified FHA from B. pertussis. This product is present as 95% in its original 220 kDa form, with 5% in the reported breakdown products of 140 kDa and 90 kDa.
Product Specifications
Type
Others
Source
Native
Assay Protocol
Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions
Reconstitution & Storage Instructions
Western Blotting/Immunoblotting (WB/IB) Protocol
Western Blotting/Immunoblotting (WB/IB) Protocol
Immunohistochemistry (IHC) Protocol
Immunohistochemistry (IHC) Protocol
Immunocytochemistry (ICC) Protocol
Immunocytochemistry (ICC) Protocol
Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
Blocking Peptide Competition Protocol (BPCP)
Blocking Peptide Competition Protocol (BPCP)
Immunoprecipitation (IP) Protocol
Immunoprecipitation (IP) Protocol
Antibody Array (AA) Protocol
Antibody Array (AA) Protocol
Concentration
0.4 mg/ml (if reconstituted as below)
Format
Lyophilized// 0.05M Tris-HCl, 0.5M sodium chloride (pH 8) with 5% sucrose
Reconstitution
Store at 2-8° C. Reconstitution of one vial with 250 uL distilled water will give a solution containing 100 ug of FHA in 0.05M Tris-HCl and 0.5M sodium chloride at pH 8, 5% sucrose. Vortex for 1 minute after reconstitution to ensure homogenous solution as protein is very sticky.
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog